Los Angeles, CA · Founded 2016 · Privately Held (backing)
Operator of a biopharmaceutical company intended to restore the brain connections and functions lost in brain injury and neurodegenerative diseases. Spinogenix is based in Los Angeles, CA and was founded in 2016. It was valued at $335 million at its later-stage round in Mar 2026, the last priced event on record. It has raised $27.4 million across 7 recorded rounds; the latest was a $10.6 million early-stage round in Nov 2025.
These 5 firms already write checks for companies like Spinogenix. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.